drugset / Trial / NCT06375031
Comparison of HR011408 and NovoRapid® in Subjects With Diabetics
RandomizedCrossoverDouble-blindTreatment
Summary
The objective of the study is to compare the pharmacokinetics and pharmacodynamics between HR011408 and NovoRapid® in Subjects with Diabetics.
Timeline
- Start
- 2024-05
- Primary completion
- 2024-07-01
- Completion
- 2024-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HR011408 | Unknown | — | — |
| Subject | insulin aspart | Protein / enzyme biologic | — | — |